BD Diagnostics, a segment
of BD BDX, a leading global medical
technology company, announced today that it received 510(k) clearance from the
U.S. Food and Drug Administration (FDA) for nasopharyngeal wash, aspirate and
swab in transport media specimens on the BD Veritor™ System for Rapid
Detection of Flu A+B. This new product is cleared for use in clinical
settings.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in